(Q38134777)

English

A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma

scientific article published on 16 April 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

0 references

A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

T-S Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Y-C Shyu

2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

H-Y Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

S-S Yuan

4

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

J-N Shih

5

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

P-J Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

publication date

16 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

729-743

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Primary liver cancer: worldwide incidence and trends

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Adjuvant therapy after curative treatment for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Interpretation of random effects meta-analyses.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Uncertainty in heterogeneity estimates in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Sustained viral response prolonged survival of patients with C-viral hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Interferon‐α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus‐related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Review article: current antiviral therapy of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12096

21 January 2018

Identifiers

10.1111/JVH.12096

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38134777&oldid=1743343846"